24-week real world outcomes of nemolizumab in patients with prurigo nodularis
Backgrounds Prurigo nodularis (PN) is a chronic pruritic inflammatory disease associated with immune and neural dysregulation. Although nemolizumab has demonstrated efficacy in clinical trials, real-world post-marketing data remain limited.Objective To evaluate the real-world efficacy, safety, and d...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2026-12-01
|
| Serier: | Journal of Dermatological Treatment |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/09546634.2026.2624225 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|